Copenhagen, Denmark; November 7, 2013 – Genmab A/S (OMX: GEN) announced today that six Genmab abstracts which include data on daratumumab, ofatumumab and the novel HexaBody™ technology have been accepted for presentation at the 55th American Society of Hematology (ASH) Annual Meeting and Exposition December 7-11 in New Orleans, Louisiana. The abstracts are available on the ASH website at www.hematology.org.
Help employers find you! Check out all the jobs and post your resume.
